DXM and codeine syrup medicine help with symptoms of colds. these medicines can be safe and effective when they are taken as instructed.

The global DXM and Codeine Syrup market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on DXM and Codeine Syrup volume and value at global level, regional level and company level. From a global perspective, this report represents overall DXM and Codeine Syrup market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of DXM and Codeine Syrup in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their DXM and Codeine Syrup manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Atley Pharmaceuticals
Vertical Pharmaceuticals
Novartis
Merck
Johnson & Johnson
Toray Industries
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
DXM
Promethazine-codeine Cough Syrup

Segment by Application
Adult
Children